Novo Nordisk snaps up Inversago Pharma for up to $1B+ on the back of megablockbuster Wegovy sales
On the back of reporting megablockbuster sales of Wegovy, Novo Nordisk has snapped up Inversago Pharma for up to $1.075 billion in a deal that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
